Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2015

The following table summarizes the restricted stock activity for the three months ended March 31, 2015:

Restricted stock units as of January 1, 2015		-
Granted		42,000
Forfeited		-
Total Restricted stock units at March 31, 2015		42,000
Vested at March 31, 2015		-
Unvested restricted stock units as of March 31, 2015		42,000

A summary of the stock option activity and related information for the Plans for the three months ended March 31, 2015 is as follows:

					Weighted-
			Weighted-		Average		Aggregate
			Average		Remaining		Intrinsic
	Shares		Exercise Price		Contractual Term		Value
Outstanding at January 1, 2015		1,226,800	$	12.40		9.00	$
Grants		456,643	$	5.95		9.91	$
Exercised		-
Forfeitures or expirations		(34,000)	$	8.09
Outstanding at March 31, 2015		1,649,443	$	10.71		9.06	$	168,958

Vested and expected to vest at March 31, 2015		1,649,443	$	10.71		9.06	$	168,958
Exercisable at March 31, 2015		406,754	$	18.69		7.79	$	2,643

The assumptions used in the valuation of stock options granted during the three months ended March 31, 2015 and 2014 were as follows:

	Three Months			Three Months
	Ended			Ended
	March 31,			March 31,
	2015			2014
Risk-free interest rate		1.47% to 1.94	%		2.19	%
Expected term of option		6.0 to 9.91 years			6.0 years
Expected stock price volatility		90.35% to 92.13	%		100.73	%
Expected dividend yield	$	0.0		$	0.0